Standard
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria : A three months prospective study. / Noshela Ghazanfar, Misbah; Bartko, Ewa Anna; Arildsen, Nicolai Skovbjerg; Poulsen, Lars K; Jensen, Bettina Margrethe; Enevold, Christian; Holm, Jesper Grønlund; Woetmann, Anders; Ødum, Niels; Thomsen, Simon Francis.
I:
Clinical and Experimental Allergy, Bind 52, 2022.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning
Harvard
Noshela Ghazanfar, M, Bartko, EA
, Arildsen, NS, Poulsen, LK, Jensen, BM, Enevold, C, Holm, JG
, Woetmann, A, Ødum, N & Thomsen, SF 2022, '
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study',
Clinical and Experimental Allergy, bind 52.
https://doi.org/10.1111/cea.14121APA
Noshela Ghazanfar, M., Bartko, E. A.
, Arildsen, N. S., Poulsen, L. K., Jensen, B. M., Enevold, C., Holm, J. G.
, Woetmann, A., Ødum, N., & Thomsen, S. F. (2022).
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study.
Clinical and Experimental Allergy,
52.
https://doi.org/10.1111/cea.14121Vancouver
Noshela Ghazanfar M, Bartko EA
, Arildsen NS, Poulsen LK, Jensen BM, Enevold C o.a.
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study.
Clinical and Experimental Allergy. 2022;52.
https://doi.org/10.1111/cea.14121Author
Noshela Ghazanfar, Misbah ; Bartko, Ewa Anna ; Arildsen, Nicolai Skovbjerg ; Poulsen, Lars K ; Jensen, Bettina Margrethe ; Enevold, Christian ; Holm, Jesper Grønlund ; Woetmann, Anders ; Ødum, Niels ; Thomsen, Simon Francis. / Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria : A three months prospective study. I: Clinical and Experimental Allergy. 2022 ; Bind 52.
Bibtex
@article{29cf65aeac8c4242a9e17045e706ceb0,
title = "Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study",
author = "{Noshela Ghazanfar}, Misbah and Bartko, {Ewa Anna} and Arildsen, {Nicolai Skovbjerg} and Poulsen, {Lars K} and Jensen, {Bettina Margrethe} and Christian Enevold and Holm, {Jesper Gr{\o}nlund} and Anders Woetmann and Niels {\O}dum and Thomsen, {Simon Francis}",
year = "2022",
doi = "10.1111/cea.14121",
language = "English",
volume = "52",
journal = "Clinical Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
}
RIS
TY - JOUR
T1 - Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria
T2 - A three months prospective study
AU - Noshela Ghazanfar, Misbah
AU - Bartko, Ewa Anna
AU - Arildsen, Nicolai Skovbjerg
AU - Poulsen, Lars K
AU - Jensen, Bettina Margrethe
AU - Enevold, Christian
AU - Holm, Jesper Grønlund
AU - Woetmann, Anders
AU - Ødum, Niels
AU - Thomsen, Simon Francis
PY - 2022
Y1 - 2022
U2 - 10.1111/cea.14121
DO - 10.1111/cea.14121
M3 - Comment/debate
C2 - 35278253
VL - 52
JO - Clinical Allergy
JF - Clinical Allergy
SN - 0954-7894
ER -
